1. Search Result
Search Result
Results for "

22:0 PC

" in MedChemExpress (MCE) Product Catalog:

5

Inhibitors & Agonists

2

Isotope-Labeled Compounds

1

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-156633

    PC14586

    MDM-2/p53 Cancer
    Rezatapopt (PC14586) is an orally active antineoplastic agent. Rezatapopt binds to a pocket created by the TP53 Y220C mutation. Rezatapopt restores p53 tumor suppressor functions by stabilization of the p53 protein structure. Rezatapopt demonstrates tumor inhibition and regression in mouse models with established human tumor xenografts harboring the TP53 Y220C mutation .
    Rezatapopt
  • HY-W839203

    1,2-Didocosanoyl-sn-glycero-3-phosphocholine; PC(22:0/22:0)

    Others Endogenous Metabolite Others
    22:0 PC (1,2-Didocosanoyl-sn-glycero-3-phosphocholine), a type of phosphatidylcholine, functions as a lung surfactant and is characterized as an amphipathic molecule predominantly found in the outer leaflets of biological membrane bilayers.
    22:0 PC
  • HY-144086S

    Isotope-Labeled Compounds Others
    22:0 Lyso-PC-d4 is the deuterium labeled 22:0 Lyso-PC .
    22:0 Lyso-PC-d4
  • HY-143857S

    Isotope-Labeled Compounds Others
    22:0 Lyso PC- 13C6 is a 13C-labeled and deuterium labeled 22:0 Lyso PC .
    22:0 Lyso PC-13C6
  • HY-172872

    CDK Apoptosis Cancer
    CDK2-IN-45 (Compound 8f) is a CDK2 inhibitor (IC50: 0.64 μM). CDK2-IN-45 inhibits the proliferation of DU-145 and PC-3 cell lines with IC50 of 2.20 μM and 4.17 μM, respectively. CDK2-IN-45 induces G0/G1 cell cycle arrest and apoptosis. CDK2-IN-45 can be used in prostate cancer research .
    CDK2-IN-45

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: